MENU
NGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NervGen Pharma (NGEN) Earnings Date & Reports
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions... Show more
A.I. Advisor
published Earnings
NGEN is expected to report earnings to fall 103.77% to 0 cents per share on November 12
Q3'26
Est.
$0.01
Q2'26
Missed
by $0.20
Q1'26
Beat
by $0.06
Q4'25
Missed
by $0.22
The last earnings report on August 13 showed earnings per share of -26 cents, missing the estimate of -6 cents. With 126.71K shares outstanding, the current market capitalization sits at 143.01M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
112-970 Burrard Street
Phone
+1 778 731-1711
Employees
18
Web
https://www.nervgen.com